Analysts’ Recommendations for Amgen and Merck

Stock price movements

Amgen (AMGN) closed at $191.16 on March 1, 0.57% higher than its previous closing price, 17.05% higher than its 52-week low of $163.31, and 9.05% below its 52-week high of $210.19. Its market capitalization was $121.77 billion, and its trailing and forward PE ratios were 15.17x and 12.84x, respectively.

Amgen released its fourth-quarter results on January 29, and its stock rose 0.36% from $190.48 on January 28 to $191.16 on March 1. The company beat analysts’ average revenue and EPS estimates by $390 million and $0.15, respectively, in the fourth quarter.

Merck (MRK) closed at $81.65 on March 1, 0.44% higher than its previous closing price, 54.55% higher than its 52-week low of $52.83, and 0.13% below its 52-week high of $81.76. Its market capitalization was $217.35 billion, and its trailing and forward PE ratios were 35.09x and 15.72x, respectively.

Merck released its fourth-quarter results on February 1, and its stock rose 9.70% from $74.43 on January 31 to $81.65 on March 1. The company beat analysts’ average revenue and EPS estimates by $50 million and $0.01, respectively, in the fourth quarter. Amgen’s trailing and forward PE ratios are lower than Merck’s.

Analysts’ Recommendations for Amgen and MerckAnalysts’ recommendations and target prices

Most analysts recommend “buy” for Amgen and Merck. Of the 23 analysts covering Amgen, five recommend “strong buy,” five recommend “buy,” and 13 recommend “hold.” Their average 12-month target price is $205.62, 7.56% higher than its March 1 closing price. Their highest, median, and lowest target prices for the stock are $234, $205, and $179, respectively.

Of the 16 analysts covering Merck, six recommend “strong buy,” eight recommend “buy,” and two recommend “hold.” Their average 12-month target price is $84.02, 2.90% higher than its March 1 closing price. The highest, median, and lowest target prices for the stock are $95, $86, and $63, respectively. Next, we’ll look at Amgen’s and Merck’s revenue growth.